GeneReport

GeneReport

genereport_cancerappy

CancerAppy is pleased to announce that some new applications are now available in their proprietary platform.

One of them is the GeneReport tool, a personalized treatment matched application, that permits score predicted treatments with patient genomic actionable information.

Oncologists and physicians involved in cancer care, can easily match genomic information from patients with therapeutic options given alone or in combination. GeneReport provides the full information that a healthcare provider need to know to offer the maximum quality care.

GeneReport can reduce time, increase accuracy and help to select the best therapeutic options from all FDA approved drugs independently of the type of cancer, based on the patient genomic information. It is a necessary tool for physician teams involved in the treatment decision-making process of cancer patients. 

Request a sample 

SOSA – BEAZ program

SOSA – BEAZ program

premiosanjuan20

This year 2021 starts very strong for Cancerappy

“Our project has been selected for the SOSA Tel Aviv-Beaz Bizkaia acceleration program.”

Hopefully, and as long as the covid19 let us, in May we will be in Tel Aviv developing our skills and networking with local companies. Now, to start, in online format.

Cancerappy awarded the prize for entrepreneurial initiative

Cancerappy awarded the prize for entrepreneurial initiative

premiosanjuan20

Award #Premiosanjuan20 for Cancerappy… and its investors.

In this month the emblematic San Juan 2020 Awards of the Albacete Business Association took place in which, this year, Luis Martín, our CEO and Co-founder of Cancerappy, has been awarded the prize for entrepreneurial initiative.

In these moments of recognition, we cannot forget that Cancerappy would not have been possible without investors. For this reason, we want to thank and make part of this award to all the  invertors that has strongly committed to promoting our cancer research project from the beginning.